(Reuters) – Johnson & Johnson reported a higher-than-expected quarterly profit and raised its full-year forecast as the company gained from strong sales of its new cancer drugs.

Continue reading on Reuters

More from this author

View all posts

Leave a Reply

Your email address will not be published. Required fields are marked *